After 3 months , 22 patients ( 0.449 ) had favorable clinical outcomes ( mRS 0 - 2 ) , whereas 7 ( 0.143 ) had poor outcomes ( mRS 3 - 5 ) ; overall mortality was 0.408 ( 20 / 49 ) .